Holmes Herbs Creates Holmes Biopharma Division

SCOTTSDALE, Arizona Aug. 24, 2005--Holmes Herbs, Inc., (OTCBB:HMHB),
announced today that it has created a division called Holmes
Biopharma, for the purpose of entering into the clinical drug
research and drug development business.

The company has launched a new website for investors and clients at
www.holmesherbs.com and www.holmesbiopharma.com.

"Our strategy is to create one new drug research facility and
acquire another existing facility in the coming months" stated John
Metcalfe, President and CEO.

On behalf of the Board of Directors

John F. Metcalfe, President and CEO

Certain statements in this press release constitute "forward looking
statements" within the meaning of the United States Securities
Legislation. The Company's actual results could differ from those in
the forward-looking statements. Do not construe this information as
investment advice. This is not a solicitation to buy or sell
securities. This does not purport to be a complete analysis of the
Company. Investing in securities is speculative and carries a high
degree of risk. Past performance does not guarantee future results.
Readers should consult their own independent advisers with any
investment, including any contemplated investment. All information
contained in this press release should be independently
investigated. This press release contains forward-looking
statements. These remarks involve risks and uncertainties. Risks are
not limited to quarterly fluctuations in results or the companies'
management of growth and competition. Other risks are detailed in
the Company's SEC filings. Actual results may differ materially from
such information set forth herein.

Holmes Herbs, Inc. (OTC Bulletin Board:HMHB)

Arizona Biotech

Biotech News

Arizona Entrepreneurs

Arizona High Tech